Hanall Biopharma Co. Ltd.

Hanall Biopharma Co. Ltd. is a South Korean pharmaceutical company engaged in the research, development, production, and sale of biopharmaceutical products. Its primary function is to contribute to global health care through the creation of innovative drugs and therapies. Hanall Biopharma focuses on critical areas such as autoimmune diseases, ophthalmology, and oncology, striving to develop targeted solutions to meet unmet medical needs. The company is particularly noted for its biopharmaceutical and biosimilar products, which are significant in treating a range of serious conditions. In the financial market, Hanall Biopharma plays a critical role as an emerging player in the biopharma sector, recognized for its commitment to research and development and its collaborations with other international pharmaceutical firms. It has garnered attention for its strategic partnerships aimed at advancing novel treatments globally, thereby marking its presence in the global health landscape.

CEO

정승원, 박수진

Employees

304

Website

hanall.co.kr